Pharmacosmos Overview
- Year Founded
-
1965
- Status
-
Private
- Employees
-
700
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
- Investments
-
3
Pharmacosmos General Information
Description
Developer of medicines for the treatment of iron deficiency anaemia in humans and animals. The company is engaged in research and development for the synthesis of iron-carbohydrate complexes to bring better treatments for patients suffering from iron deficiency.
Contact Information
Website
www.pharmacosmos.comCorporate Office
- Roervangsvej 30
- 4300 Holbaek
- Denmark
Corporate Office
- Roervangsvej 30
- 4300 Holbaek
- Denmark
Pharmacosmos Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Pharmacosmos Comparisons
Industry
Financing
Details
Pharmacosmos Competitors (6)
One of Pharmacosmos’s 6 competitors is Idorsia Pharmaceuticals, a Corporation company based in Allschwil, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Idorsia Pharmaceuticals | Corporation | Allschwil, Switzerland | ||||
| Akebia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Regen BioPharma | Corporation | La Mesa, CA | ||||
| Ascentage Pharma | Formerly VC-backed | Suzhou, China | ||||
| Fresenius Kabi | Corporation | Bad Homburg, Germany |
Pharmacosmos Patents
Pharmacosmos Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022323733-A1 | Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals | Pending | 03-Aug-2021 | ||
| CA-3226771-A1 | Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals | Pending | 03-Aug-2021 | ||
| EP-4380581-A1 | Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals | Pending | 03-Aug-2021 | ||
| US-20260108551-A1 | Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals | Pending | 03-Aug-2021 | ||
| WO-2023012242-A1 | Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals | Inactive | 03-Aug-2021 | A61K33/26 |
Pharmacosmos Signals
Pharmacosmos Investments & Acquisitions (3)
Pharmacosmos’s most recent deal was a Later Stage VC with Incyclix Bio for . The deal was made on 08-Apr-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Incyclix Bio | 08-Apr-2026 | Later Stage VC | Drug Discovery | ||
| G1 Therapeutics | 18-Sep-2024 | Merger/Acquisition | Drug Discovery | ||
| Abfero Pharmaceuticals | 11-Nov-2021 | Merger/Acquisition | Drug Discovery |
Pharmacosmos Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| pharmacosmos deutschland | Wiesbaden, Germany | 2016 | |
| Abfero Pharmaceuticals | Boston, MA | 2016 | |
| Pharmacosweden | Stockholm, Sweden | 2011 | |
| Pharmacosmos Uk | Reading, United Kingdom | 1995 |
Pharmacosmos FAQs
-
When was Pharmacosmos founded?
Pharmacosmos was founded in 1965.
-
Where is Pharmacosmos headquartered?
Pharmacosmos is headquartered in Holbaek, Denmark.
-
What is the size of Pharmacosmos?
Pharmacosmos has 700 total employees.
-
What industry is Pharmacosmos in?
Pharmacosmos’s primary industry is Drug Discovery.
-
Is Pharmacosmos a private or public company?
Pharmacosmos is a Private company.
-
What is Pharmacosmos’s current revenue?
The current revenue for Pharmacosmos is .
-
Who are Pharmacosmos’s competitors?
Idorsia Pharmaceuticals, Akebia Therapeutics, Regen BioPharma, Ascentage Pharma, and Fresenius Kabi are some of the 6 competitors of Pharmacosmos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process